Q: What does Tongli do?
Tongli Pharmaceutical (USA), Inc. develops, manufactures and markets pharmaceutical and health care products through its wholly-owned subsidiary, Harbin Tianmu Pharmaceutical Co., Ltd. (“Tianmu Pharmaceutical”).  Tianmu Pharmaceutical was founded in 1999 in Harbin, hub of the Northern Pharmaceutical base of China. The company acquired the GMP certificate in 2003. With a cohesive management team and committed staff, Tongli is providing the best quality pharmaceutical products at a very competitive price. The company is targeting the vast Chinese market with a vision of extending its footprint to East Asia and Russia.
Q: When did Tongli go public?
A: Tongli was listed on the OTC Bulletin Board on July 29, 2008.

Q: Can I purchase Tongli stock directly from the Company?
A: No, we do not offer investors a direct stock purchase plan. Investors must purchase Tongli stock through a licensed brokerage firm in the public market.